A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Public ClinicalTrials.gov record NCT06664619. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 4-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Fluticasone Propionate/Albuterol Sulfate Combination Compared to Fluticasone Propionate, Albuterol Sulfate or Placebo Delivered by Multidose Dry Powder Inhaler in Participants 12 Years and Older With Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To evaluate the safety and tolerability of Fp/ABS eMDPI administered four times daily over four weeks * To investigate the pharmacokinetics of Fp/ABS eMDPI, ABS eMDPI and Fp eMDPI after administration of a single dose The planned study duration for each participant is approximately 10 weeks, excluding an optional prescreening visit.
Study identification
- NCT ID
- NCT06664619
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 649 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 12, 2024 (Actual)
- Primary completion
- Nov 2, 2026 (Estimated)
- Completion
- Nov 2, 2026 (Estimated)
- Last update posted
- Oct 6, 2026
2024 – 2026
United States locations
- U.S. sites
- 91
- U.S. states
- 27
- U.S. cities
- 76
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 12087 | Phoenix | Arizona | 85015 | — |
| Teva Investigational Site 12144 | Phoenix | Arizona | 85020 | — |
| Teva Investigational Site 12104 | Tucson | Arizona | 85715 | — |
| Teva Investigational Site 12146 | Tucson | Arizona | 85741 | — |
| Teva Investigational Site 12102 | Little Rock | Arkansas | 72205 | — |
| Teva Investigational Site 12154 | Encinitas | California | 92024-2812 | — |
| Teva Investigational Site 12103 | Huntington Beach | California | 92647 | — |
| Teva Investigational Site 12068 | La Palma | California | 90623 | — |
| Teva Investigational Site 12152 | Laguna Niguel | California | 92677 | — |
| Teva Investigational Site 12145 | Long Beach | California | 90815 | — |
| Teva Investigational Site 12088 | Los Angeles | California | 90048 | — |
| Teva Investigational Site 12094 | Los Angeles | California | 93551 | — |
| Teva Investigational Site 12161 | Northridge | California | 91324 | — |
| Teva Investigational Site 12105 | Oxnard | California | 93030-5822 | — |
| Teva Investigational Site 12101 | Sacramento | California | 95821 | — |
| Teva Investigational Site 12064 | San Jose | California | 95117 | — |
| Teva Investigational Site 12109 | Upland | California | 91786 | — |
| Teva Investigational Site 12070 | Vista | California | 92083 | — |
| Teva Investigational Site 12091 | Walnut Creek | California | 94598 | — |
| Teva Investigational Site 12142 | Lakewood | Colorado | 80228 | — |
| Teva Investigational Site 12098 | Lake City | Florida | 32055-4880 | — |
| Teva Investigational Site 12118 | Lake Worth | Florida | 33460-4400 | — |
| Teva Investigational Site 12079 | Melbourne | Florida | 32934 | — |
| Teva Investigational Site 12071 | Miami | Florida | 33126 | — |
| Teva Investigational Site 12074 | Miami | Florida | 33135 | — |
| Teva Investigational Site 12086 | Miami | Florida | 33173 | — |
| Teva Investigational Site 12061 | Miami | Florida | 33174 | — |
| Teva Investigational Site 12097 | Miami | Florida | 33175 | — |
| Teva Investigational Site 12092 | Miami Lakes | Florida | 33014 | — |
| Teva Investigational Site 12076 | North Miami Beach | Florida | 33169 | — |
| Teva Investigational Site 12095 | Palmetto Bay | Florida | 33157 | — |
| Teva Investigational Site 12075 | Pompano Beach | Florida | 33064 | — |
| Teva Investigational Site 12078 | Tampa | Florida | 33607 | — |
| Teva Investigational Site 12175 | Conyers | Georgia | 30012 | — |
| Teva Investigational Site 12156 | Boise | Idaho | 83706 | — |
| Teva Investigational Site 12162 | Westchester | Illinois | 60154 | — |
| Teva Investigational Site 12169 | Shreveport | Louisiana | 71105 | — |
| Teva Investigational Site 12081 | Nottingham | Maryland | 21236 | — |
| Teva Investigational Site 12106 | Towson | Maryland | 21204 | — |
| Teva Investigational Site 12157 | White Marsh | Maryland | 21162-5503 | — |
| Teva Investigational Site 12119 | Boston | Massachusetts | 02115 | — |
| Teva Investigational Site 12182 | South Dartmouth | Massachusetts | 02747 | — |
| Teva Investigational Site 12187 | Brighton | Michigan | 48116 | — |
| Teva Investigational Site 12073 | Minneapolis | Minnesota | 55402-2606 | — |
| Teva Investigational Site 12066 | Richfield | Minnesota | 55423 | — |
| Teva Investigational Site 12149 | Columbia | Missouri | 65203 | — |
| Teva Investigational Site 12108 | St Louis | Missouri | 63110 | — |
| Teva Investigational Site 12089 | St Louis | Missouri | 63141 | — |
| Teva Investigational Site 12158 | Hastings | Nebraska | 68901 | — |
| Teva Investigational Site 12160 | Las Vegas | Nevada | 89113 | — |
| Teva Investigational Site 12150 | Las Vegas | Nevada | 89119 | — |
| Teva Investigational Site 12110 | Jersey City | New Jersey | 07306 | — |
| Teva Investigational Site 12115 | Charlotte | North Carolina | 28207 | — |
| Teva Investigational Site 12185 | High Point | North Carolina | 27260 | — |
| Teva Investigational Site 12085 | Raleigh | North Carolina | 27607-6689 | — |
| Teva Investigational Site 12063 | Toledo | Ohio | 43617 | — |
| Teva Investigational Site 12178 | Oklahoma City | Oklahoma | 73120 | — |
| Teva Investigational Site 12155 | Tulsa | Oklahoma | 74133 | — |
| Teva Investigational Site 12170 | Tulsa | Oklahoma | 74136 | — |
| Teva Investigational Site 12117 | Clackamas | Oregon | 97015 | — |
| Teva Investigational Site 12151 | Portland | Oregon | 97202 | — |
| Teva Investigational Site 12147 | Horsham | Pennsylvania | 19044 | — |
| Teva Investigational Site 12072 | Philadelphia | Pennsylvania | 19107 | — |
| Teva Investigational Site 12114 | Pittsburgh | Pennsylvania | 15241 | — |
| Teva Investigational Site 12067 | Columbia | South Carolina | 29204 | — |
| Teva Investigational Site 12111 | Myrtle Beach | South Carolina | 29572 | — |
| Teva Investigational Site 12112 | North Charleston | South Carolina | 29420 | — |
| Teva Investigational Site 12107 | Rock Hill | South Carolina | 29732 | — |
| Teva Investigational Site 12083 | Austin | Texas | 78744 | — |
| Teva Investigational Site 12060 | Austin | Texas | 78759 | — |
| Teva Investigational Site 12077 | Corsicana | Texas | 75110-2471 | — |
| Teva Investigational Site 12179 | Cypress | Texas | 77429 | — |
| Teva Investigational Site 12159 | Dallas | Texas | 75225-6301 | — |
| Teva Investigational Site 12171 | Dallas | Texas | 75235 | — |
| Teva Investigational Site 12090 | Dallas | Texas | 75243 | — |
| Teva Investigational Site 12143 | El Paso | Texas | 79912 | — |
| Teva Investigational Site 12181 | Houston | Texas | 77008-1528 | — |
| Teva Investigational Site 12168 | Houston | Texas | 77018 | — |
| Teva Investigational Site 12184 | Houston | Texas | 77065 | — |
| Teva Investigational Site 12176 | Kerrville | Texas | 78028 | — |
| Teva Investigational Site 12080 | Kingwood | Texas | 77339 | — |
| Teva Investigational Site 12096 | McKinney | Texas | 75069 | — |
| Teva Investigational Site 12113 | Mesquite | Texas | 75150 | — |
| Teva Investigational Site 12166 | Sugar Land | Texas | 77479 | — |
| Teva Investigational Site 12183 | Tomball | Texas | 77081 | — |
| Teva Investigational Site 12084 | Victoria | Texas | 77901 | — |
| Teva Investigational Site 12148 | Pleasant View | Utah | 84404-4791 | — |
| Teva Investigational Site 12082 | Salt Lake City | Utah | 84123 | — |
| Teva Investigational Site 12153 | South Ogden | Utah | 84405 | — |
| Teva Investigational Site 12093 | Portsmouth | Virginia | 23703 | — |
| Teva Investigational Site 12062 | Greenfield | Wisconsin | 53228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06664619, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2026 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06664619 live on ClinicalTrials.gov.